Patent intelligence · US
US 11141404
Formulations and methods for treating acute cannabinoid overdose
Formulations and methods for treating acute cannabinoid overdose
Patent details — US 11141404
- Jurisdiction
- US
- Status
- granted
- Grant date
- Oct 12, 2021
- Expiration
- Oct 7, 2041
- Applicant
- Anebulo Pharmaceuticals, Inc.
- Claims
- 16
- CPC classes
- A61K, A61K31/397, A61K9/0019, A61K9/0043
Quick answer
US 11141404 (Formulations and methods for treating acute cannabinoid overdose) is held by Anebulo Pharmaceuticals, Inc.. Status: granted. Granted Oct 12, 2021. Expires Oct 7, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Anebulo Pharmaceuticals, Inc.
- Grant date
- Expiration
- Claims
- 16
- CPC classes
- A61K, A61K31/397, A61K9/0019, A61K9/0043, A61K9/006, A61K9/0073
Frequently asked questions
What is US patent 11141404?
US 11141404 (Formulations and methods for treating acute cannabinoid overdose) is held by Anebulo Pharmaceuticals, Inc.. Status: granted. Granted Oct 12, 2021. Expires Oct 7, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11141404?
Anebulo Pharmaceuticals, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 1 pharmaceutical patents for this assignee.
When does US 11141404 expire?
Our index shows an expiration date of Oct 7, 2041 (15 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.